CRISPR-Cas9—The Potential “Holy Grail” for Generating Biomedically Relevant Cells through Cell Fate Engineering
Re:GEN Open · 2021
DOI: 10.1089/regen.2021.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Re:GEN Open, 2021. Verfasst von Vignesh Krishnamoorthy und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben.
Abstract (Originalsprache)
Background
The main goal of cellular therapy is to effectively engineer the fate of stem/progenitor/terminally differentiated cells into desired lineages to promote therapeutic tissue regenerative effects. Numerous methods such as ectopic transgene overexpression, small molecules, micro RNAs, and CRISPR-Cas9 have been used to engineer cell fate.
Objective
In this review, we have attempted to highlight various cell fate engineering strategies with a particular emphasis on transdifferentiation that involves CRISPR-Cas9-based approaches in what appear to be the most promising and medically relevant preclinical models.
Methods
A large number of recent publications involving the application of CRISPR-Cas9-based gene regulation strategies in modulating the identities of different cell types for promoting efficacious tissue regeneration were reviewed.
Results
From the literature, it appears that the ability to manipulate endogenous gene expression programs has dramatically increased with the help of CRISPR-Cas9-based gene activation/repression/knockout strategies. These approaches have also enabled the generation of cells that closely resemble their true cellular counterparts. Also, in most cases, the efficacy of cell fate engineering through the CRISPR-Cas9-based technology is quite comparable to other methods of cell fate manipulation and in some instances superior.
Conclusion
The reviewed studies demonstrate novel ways in manipulating cellular identities for regenerative medicine applications using the CRISPR-Cas9-based genome editing tool. Transdifferentiating certain cell types into another using CRISPR-Cas9 seems to have enjoyed more success in comparison to conventional methods. These findings highlight the favorable attributes of the CRISPR-Cas9-based technology in cell-based therapies and their potential use in the near future.
Zitieren
APA
Krishnamoorthy, V., & Haigh, J. J. (2021). CRISPR-Cas9—The Potential “Holy Grail” for Generating Biomedically Relevant Cells through Cell Fate Engineering. Re:GEN Open. https://doi.org/10.1089/regen.2021.0003
Vancouver
Krishnamoorthy V, Haigh JJ. CRISPR-Cas9—The Potential “Holy Grail” for Generating Biomedically Relevant Cells through Cell Fate Engineering. Re:GEN Open. 2021. doi:10.1089/regen.2021.0003
BibTeX
@article{Krishnamoorthy2021,
author = {Krishnamoorthy, Vignesh and Haigh, Jody J.},
title = {CRISPR-Cas9—The Potential “Holy Grail” for Generating Biomedically Relevant Cells through Cell Fate Engineering},
journal = {Re:GEN Open},
year = {2021},
doi = {10.1089/regen.2021.0003}
}
EUVIMED